Prothena Corp Public (PRTA) EPS (Basic) (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly EPS (Basic) came in at $0.61 in Q1 2026, up 154.48% year-on-year from $0.24 in Q1 2025, and up 252.24% quarter-over-quarter from -$0.4 in Q4 2025.
Prothena Corp Public (PRTA) EPS (Basic) (2012 - 2026) Analysis & Trends
Prothena Corp Public's EPS (Basic) history runs 15 years deep, the most recent figure standing at $0.61 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 154.48% year-over-year to $0.61 in Q1 2026; TTM through Mar 2026 was -$2.81, a 37.21% decrease from a year earlier, with the FY2025 full-year figure at -$4.53, down 99.36% from the prior year.
- EPS (Basic) rose to $0.61 in Q1 2026 per PRTA's latest filing, from -$0.4 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.24 in Q2 2024 and bottomed at -$2.34 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.89 (2023), against an average of -$0.68.
- Across the five-year window, EPS (Basic) sank 1046.01% in 2023 and jumped 220.96% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at $0.13 in 2022, then tumbled by 1046.01% to -$1.27 in 2023, then rose by 14.96% to -$1.08 in 2024, then surged by 62.89% to -$0.4 in 2025, then surged by 252.24% to $0.61 in 2026.
- Per Business Quant, the three latest PRTA EPS (Basic) figures stand at $0.61 (Q1 2026), -$0.4 (Q4 2025), and -$0.68 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | 0.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.61 |
| Dec 31, 2025 | -0.40 |
| Sep 30, 2025 | -0.68 |
| Jun 30, 2025 | -2.34 |
| Mar 31, 2025 | -1.12 |
| Dec 31, 2024 | -1.08 |
| Sep 30, 2024 | -1.10 |
| Jun 30, 2024 | 1.24 |
| Mar 31, 2024 | -1.34 |
| Dec 31, 2023 | -1.27 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | -1.03 |
| Mar 31, 2023 | -0.89 |
| Dec 31, 2022 | 0.13 |
| Sep 30, 2022 | -0.97 |
| Jun 30, 2022 | -0.88 |
| Mar 31, 2022 | -0.78 |
| Dec 31, 2021 | -0.75 |
| Sep 30, 2021 | 2.39 |
| Jun 30, 2021 | 0.62 |